HCV treatment initiation in the era of universal direct acting antiviral coverage – Improvements in access and persistent barriers-Reference-Cited by-同舟云学术

HCV treatment initiation in the era of universal direct acting antiviral coverage – Improvements in access and persistent barriers

Published:2023-03 Issue: Volume:113 Page:103954
ISSN:0955-3959
Container-title:International Journal of Drug Policy
language:en
Short-container-title:International Journal of Drug Policy

Author:

Jiang Nathalie,Bruneau Julie,Makarenko Iuliia,Minoyan Nanor,Zang Geng,Høj Stine Bordier^ORCID,Larney Sarah^ORCID,Martel-Laferrière Valérie

Publisher

Elsevier BV

Subject

Health Policy,Medicine (miscellaneous)

Reference70 articles.

1. Welcomeness for people with substance use disorders to general practice: A qualitative study;Abbott;Family Practice,2021

2. Hepatitis C elimination among people incarcerated in prisons: Challenges and recommendations for action within a health systems framework;Akiyama;The Lancet Gastroenterology & Hepatology,2021

3. Patient and provider perceived barriers and facilitators to direct acting antiviral hepatitis C treatment among priority populations in high income countries: A knowledge synthesis;Amoako;International Journal of Drug Policy,2021

4. Outcomes of treatment for hepatitis C virus infection by primary care providers;Arora;New England Journal of Medicine,2011

5. Role of primary care providers in hepatitis C prevention and care: One step away from evidence-based practice;Artenie;Canadian Family Physician,2014

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Catalytic hairpin assembly triggering amplified DNAzyme-feedback for sensitive detection of hepatitis C virus genotype 1b;Talanta;2024-05

2. Hepatitis C Cascade of Care in the Direct-Acting Antivirals Era: A Meta-Analysis;American Journal of Preventive Medicine;2023-12